Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03CHA
|
||||
| Former ID |
DIB011968
|
||||
| Drug Name |
CB1 antagonists
|
||||
| Synonyms |
CB1 antagonists (metabolic syndrome); CB1 antagonists (metabolic syndrome), Esteve
|
||||
| Indication | Metabolic disorders [ICD9: 270-279; ICD10:E70-E89] | Investigative | [552166] | ||
| Company |
Esteve
|
||||
| Canonical SMILES |
c1(ccc(cc1Cl)Cl)N1[C@@H]([C@@H](C(=N1)C(=O)NN1[C@@H](CC<br />C[C@@H]1C)C)C)c1ccc(cc1)Cl.Cl
|
||||
| Target and Pathway | |||||
| Target(s) | Cannabinoid receptor 1 | Target Info | Antagonist | [543877] | |
| PANTHER Pathway | Endogenous cannabinoid signaling | ||||
| Pathway Interaction Database | N-cadherin signaling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.